InTechOpen uses cookies to offer you the best online experience. By continuing to use our site, you agree to our Privacy Policy.

Agricultural and Biological Sciences » "Soybean and Health", book edited by Hany El-Shemy, ISBN 978-953-307-535-8, Published: September 12, 2011 under CC BY-NC-SA 3.0 license. © The Author(s).

Chapter 4

The Effect of Flavonoids in Soybean Products in Lymphocytes from IBD and Colon Cancer Patients After Treatment with Food Mutagens and Hydrogen Peroxide

By Mojgan Najafzadeh, Malgorzata Kurzawa-Zegota, Adolf Baumgartner, P. Dominic Reynolds, Justin B. Davies and Diana Anderson
DOI: 10.5772/20190

Article top


IBD patient group and control group after in vitro treatment with A) H2O2 (50 μM) and supplementation with the flavonoid quercetin (Quer) at different concentration levels and B) IQ (50 μM) and supplementation with the flavonoid epicatechin (Epi) at different concentration levels. Pooling the data for each group and comparing median levels of DNA damage and 75% quartiles showed them to be significantly different (Kolmogorov-Smirnov test, p < 0.001). The º symbols followed by a number indicate individual outliers with the respective patient number.
Figure 1. IBD patient group and control group after in vitro treatment with A) H2O2 (50 μM) and supplementation with the flavonoid quercetin (Quer) at different concentration levels and B) IQ (50 μM) and supplementation with the flavonoid epicatechin (Epi) at different concentration levels. Pooling the data for each group and comparing median levels of DNA damage and 75% quartiles showed them to be significantly different (Kolmogorov-Smirnov test, p < 0.001). The º symbols followed by a number indicate individual outliers with the respective patient number.
DNA damage within three IBD subgroups after in vitro treatment with A) H2O2 (50 μM) and supplementation with the flavonoid quercetin (Quer) at different concentration levels and B) IQ (50 μM) and supplementation with the flavonoid epicatechin (Epi) at different concentration levels. The first two groups were diagnosed with Crohn’s disease and Ulcerative Colitis. The third group was an indeterminate subgroup.
Figure 2. DNA damage within three IBD subgroups after in vitro treatment with A) H2O2 (50 μM) and supplementation with the flavonoid quercetin (Quer) at different concentration levels and B) IQ (50 μM) and supplementation with the flavonoid epicatechin (Epi) at different concentration levels. The first two groups were diagnosed with Crohn’s disease and Ulcerative Colitis. The third group was an indeterminate subgroup.
The Comet parameter % tail DNA is shown indicating DNA damage in lymphocytes after in vitro treatment with IQ (25, 75, 100 and 150 µM) and then supplementation of the highest dose with either the flavonoid quercetin (Q) [Panel A] or rutin (R) [Panel B] as well as treatment with PhIP (10, 25, 50 and 75 µM) and then supplementation of the highest dose with either the flavonoid quercetin (Q) [Panel C] or rutin (R) [Panel D]. The flavonoids were used at different concentrations from 50 µM up to 500 µM. Intergroup comparisons of healthy individuals and colon cancer patients revealed significantly increased induction of DNA damage, when treating with heterocyclic amines alone and together with flavonoids, between healthy individuals and the colon cancer patient group (* p<0.05, ** p<0.01, *** p<0.001). All other types of data comparisons are shown in Table 3.
Figure 3. The Comet parameter % tail DNA is shown indicating DNA damage in lymphocytes after in vitro treatment with IQ (25, 75, 100 and 150 µM) and then supplementation of the highest dose with either the flavonoid quercetin (Q) [Panel A] or rutin (R) [Panel B] as well as treatment with PhIP (10, 25, 50 and 75 µM) and then supplementation of the highest dose with either the flavonoid quercetin (Q) [Panel C] or rutin (R) [Panel D]. The flavonoids were used at different concentrations from 50 µM up to 500 µM. Intergroup comparisons of healthy individuals and colon cancer patients revealed significantly increased induction of DNA damage, when treating with heterocyclic amines alone and together with flavonoids, between healthy individuals and the colon cancer patient group (* p<0.05, ** p<0.01, *** p<0.001). All other types of data comparisons are shown in Table 3.

The Effect of Flavonoids in Soybean Products in Lymphocytes from IBD and Colon Cancer Patients After Treatment with Food Mutagens and Hydrogen Peroxide

Mojgan Najafzadeh1, Malgorzata Kurzawa-Zegota1, Adolf Baumgartner1, 3, P. Dominic Reynolds2, Justin B. Davies2 and Diana Anderson1

1. Introduction

The generation of DNA damage by environmental, medical or life style factors is considered to be an important initial event in carcinogenesis. At the cellular level, a balance between the production of oxidative radicals and the compensational action of antioxidants, which might become pro-oxidant at high concentrations (Anderson et al., 1994) is crucial for our health. Imbalance on either side, especially towards an increase in oxidative stress, might result in various detrimental effects including cell death and cancer. Despite various cellular mechanisms to counteract these adverse events the sheer number of potentially carcinogenic compounds leading to oxidative stress can negatively affect the DNA integrity of cells.

Dietary flavonoids acting as antioxidants (Rice-Evans, 2001) have been identified to be capable of counteracting these adverse oxidative effects (Ross and Kasum, 2002). They are classified as low-molecular-weight polyphenolic compounds that are ubiquitously present in fruit and vegetables and categorised according to their chemical structure into flavonols, flavones, flavanones, isoflavones, catechins, anthocyanidins and chalcones. Flavonoids such as quercetin and rutin present in soybean products have potent antioxidant properties and mimic oestrogens, hence are being used to ease menopausal symptoms. Soy flavonoids are also believed to lower the blood level of triglicerydes and cholesterol preventing coronary heart disease as well as osteoporosis (Valachovicova et al., 2004). They have a wide variety of biological effects acting either as anti- or pro-oxidants depending on their concentration (Anderson et al., 1997; Duthie et al., 1997) and/or in combination with food mutagens (Anderson et al., 1997). Anderson et al. observed positive responses with flavonoids when lymphocytes were treated with them alone in the Comet assay, and in combination with food mutagens they were showing exacerbating effects at low doses and were protective at high doses (Anderson et al., 1997). The antioxidant potency of several widespread dietary flavonoids showed a dose-dependent reduction of induced oxidative DNA damage in vitro, highlighting an even higher protective effect than vitamin C (Noroozi et al., 1998). It has also been shown that flavonoid intake can lower the mortality rate caused by coronary heart disease (Kaur et al., 2007). Typical flavonoids are kaempferol, quercetin and rutin (the common glycoside of quercetin), belonging to the class of flavonols. The strongest evidence for a cancer-preventive effect shows quercetin with strong antioxidant properties (Chondrogianni et al., 2010; Hollman et al., 1996). It has been reported that the average intake of flavonoids is 23 mg per day with quercetin contributing almost 70% (Hollman et al., 1996; Wach et al., 2007). As it scavenges highly reactive species such as peroxynitrite and hydroxyl radicals (Boots et al., 2008), quercetin protects not only against various diseases such as atherosclerosis, cancer, osteoporosis, pulmonary and cardiovascular diseases but also against ageing (Chondrogianni et al., 2010; Ekstrom et al., 2010; Ossola et al., 2009; Terao, 2009; Zhou et al., 2010).

Lifestyle factors like alcohol intake, physical inactivity, stress, food additives, high animal fat and/or red meat intake and also cooking-derived carcinogens such as heterocyclic amines (HCA), have been identified as having a strong impact on human health and being involved in the aetiology of cancer in general (Adamson et al., 1996; Bogen, 1994). Evidence for a positive association of colorectal cancer and adenomatous polyps with HCA exposure has been provided by several studies (Butler et al., 2003; Felton et al., 2007; Gunter et al., 2005; Knize and Felton, 2005; Murtaugh et al., 2004; Navarro et al., 2004; Nowell et al., 2002; Shin et al., 2007; Wu et al., 2006). HCA are formed by cooking proteinaceous food, mainly seen as heat-induced non-enzymatic browning that involves creatinine, free amino acids and monosaccharides (Schut and Snyderwine, 1999). More than 20 carcinogenic/mutagenic HCA have been isolated so far (Nagao et al., 1997; Wakabayashi et al., 1992). Major subclasses of HCA found in the human diet comprise of aminoimidazoazaarenes (AIA), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline (DiMeIQx) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) (Schut and Snyderwine, 1999). It has been estimated that the daily intake of HCA can reach 50 µg (Knize et al., 1995; Krul et al., 2000), depending on the type of meat, temperature and the method of cooking (Messner and Murkovic, 2004; Wu et al., 2001). The heterocyclic amine PhIP is considered to be the most abundant HCA responsible for inducing various types of tumours in rats (Felton et al., 2004).

More than 600 individual compounds and complex dietary mixtures have been studied for protective effects towards HCA (Schwab et al., 2000) and numerous articles have been published regarding mammalian enzymes involved in the bioactivation and detoxification of these compounds (Eisenbrand and Tang, 1993). The genotoxicity of HCA originates from their activation by a series of reactions involving cytochrome P450 when the parent compound is converted to an electrophilic derivative such as a nitrenium ion that covalently binds to DNA resulting in DNA adducts and subsequently in nucleotide alterations and chromosomal aberrations (Goldman and Shields, 2003; Hatch et al., 2001). IQ induces unscheduled DNA synthesis in liver cells and shows strong mutagenic properties in the Salmonella typhimurium test system, which contribute to its classification as a potent carcinogen (Maeda et al., 1999; Murata et al., 1999; Weisburger et al., 1986) Also in addition to the formation of DNA adducts, oxidative damage to the DNA itself plays a crucial role in the carcinogenic process of food mutagens (Maeda et al., 1999; Murata et al., 1999). Heterocyclic amines like IQ are able to generate free radicals in the presence of NADPH and cytochrome b5 reductase (Maeda et al., 1999).

Colorectal tissue is constantly exposed to different chemicals and free oxygen radicals formed during metabolic activation. High intracolonic levels of free radicals may form active carcinogens or mitogenic tumour promoters through the oxidation of procarcinogens, either by hydroxyl radicals in faecal water or by secondary peroxyl radicals (Babbs, 1990). Within an inflamed bowel, disproportionate amounts of reactive oxygen species (ROS) can be additionally produced (Loguercio et al., 1996; Simmonds and Rampton, 1993). Ulcerative Colitis and Crohn's disease are inflammatory disorders of the gastrointestinal tract, associated with increased risk for colorectal cancer (Soderlund et al., 2010), which are unevenly distributed within the populations throughout the world. Although the exact cause of inflammatory bowel disease (IBD) remains unknown, the epidemiology of IBD has provided an insight into the pathogenesis of the disease by examining geographic, ethnic and other IBD risk factors (genetic, environmental, etc.) as well as their natural history (Danese and Fiocchi, 2006). Interestingly, reactive oxygen species (Seegert et al., 2001) are produced in abnormally high levels in cells from IBD patients (Rezaie et al., 2007) leading to oxidative stress and thus to DNA damage due to an imbalance between innate and exogenous antioxidants and ROS (Hemnani and Parihar, 1998; Soffler, 2007). Oxidative stress has been linked to cancer, aging, atherosclerosis, ischemic injury, inflammation and neurodegenerative diseases (Davies, 1995). Oxidative stress arising from the pathophysiology of cancer, may even serve as a biomarker (Hopkins et al., 2010), when there is an imbalance between production of ROS and their removal by intrinsic antioxidants (catalase) and antioxidant micronutrients.

In the present study, we used the Comet assay, which evaluates direct DNA breaks and is a fast and reliable method to assess DNA integrity in virtually any cell type without the requirement for cell culture (Moller, 2006). Three groups of individuals served as blood donors: healthy volunteers, IBD patients as well as patients with histopathologically confirmed, untreated colon cancer. It is known that lymphocytes from colon cancer patients exhibit higher levels of DNA damage caused by the intrinsic oxidative stress arising from colorectal cancer (Hopkins et al., 2010) and that these lymphocytes may also serve as an early predictive marker of cancer risk (Vodicka et al., 2010). Separated lymphocytes from IBD patients and healthy individuals were treated with H2O2 co-treated with quercetin and IQ with epicatechin. Also lymphocytes from colon cancer patients and healthy individuals were treated with IQ and PhIP with and without the supplementation of the antioxidant flavonoids, quercetin and rutin to show that these three flavonoids are able to reliably protect cells against the damaging effects of reactive oxygen species, even in the context of diseases like IBD or colorectal cancer where levels of ROS are already highly increased. Non-physiological doses were used in vitro to study the genotoxicological responses where higher, yet non cytotoxic doses are used as a routine procedure.

2. Materials and methods

2.1. Chemicals

The chemicals for the Comet assay were purchased from the following suppliers: RPMI-1640 medium, agarose and low melting point agarose from Invitrogen, Ltd. (Paisley, U.K.); DMSO (dimethyl sulfoxide), ethidium bromide, Trypan blue, EDTA, Trizma base, Triton X-100, quercetin, epicatechin, rutin and hydrogen peroxide H2O2, from Sigma Chemical Company (Dorset, U.K.); sodium chloride and sodium hydroxide from BDH Laboratory Supplies (Poole, England); Lymphoprep cell separation gel from Nycomed Pharma Axis Shield (Oslo, Norway); FCS (foetal calf serum) from Nalgene, Rochester (New York, USA). The food mutagens, IQ (2-amino-3-methyl-3h-imidazo[4,5-f]quinoline) and PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine), were obtained from Toronto Research Chemicals, Inc. (Downsview, Ontario, Canada).

2.2. Collection of samples

After informed consent, approximately 10 ml heparinised blood were taken by venepuncture from the IBD and colon cancer patients at the Department of Gastroenterology, Bradford Royal Infirmary (BRI) and St. Luke’s Hospital, Bradford, UK. Healthy volunteers were recruited within the Division of Biomedical Sciences at the University of Bradford (West Yorkshire, UK). Ethical permission was obtained from both the BRI Local Ethics Committee (Reference no.: 04/Q1202/15) and the University of Bradford’s Sub-Committee for Ethics in Research involving Human Subjects (Reference no.: 0405/8). Over a period of three years, a set of samples from healthy controls, IBD patients and colon cancer patients was obtained.

2.3. Questionnaire for patients and controls

A questionnaire was administered to each donor immediately after taking the blood sample. The completed questionnaire for the patient and control groups provided essential information about lifestyle, endogenous (gender, age) and exogenous factors (intake of medicines and alcohol, smoking habits and diet). There were two different studies performed: study I involving IBD patients and study II – colorectal cancer patients. Both studies had separate treatment regimes.

2.4. Lymphocyte separation for the Comet assay

The heparinised blood was diluted with 0.9% saline in a 50:50 proportion and 6 ml of this dilution was carefully layered on top of 3 ml of Lymphoprep in 15 ml conical tubes followed by centrifugation (20 minutes at 800 g) at room temperature. The buffy coat layer of lymphocytes (above the Lymphoprep layer) was then transferred to another tube pre-filled with 10 ml of saline and centrifuged (15 minutes at 500 g). The supernatant was removed without disturbing the pellet which was then resuspended in PBS or RPMI-1640 medium and used for the in vitro experiments. Some of the lymphocytes were frozen in liquid nitrogen for long-term storage. In this case the pellet was resuspended in FCS containing 10% DMSO, and lodged in liquid nitrogen vapour overnight, before final storage after complete insertion in the storage Dewar.

2.5. Cell viability

Cell viability at the concentrations chosen for each experiment was checked after treatment and before performing the Comet assay. Viability was determined by Trypan blue dye exclusion indicating intact cell membranes (Phillips, 1973). 10 µl of 0.05% Trypan blue was added to 10 µl of cell suspension and the percentage of cells excluding the dye was estimated using a Neubauer Improved haemocytometer (Pool-Zobel et al., 1992). Only concentrations with viability over 80% were accepted for use in the studies to avoid artefactual results from cytotoxicity (Henderson et al., 1998).

2.6. Treatment of lymphocytes

2.6.1. Treatment for IBD group of experiments

Isolated lymphocytes (approx. 106 cells per ml) from IBD patients (n=10) and healthy controls (n=10) were treated without metabolic activation for 30 minutes in RPMI at 37 ºC either with different concentrations of quercetin (0, 100, 200, 250 µM) in the presence of hydrogen peroxide (50 µM) or with different concentrations of epicatechin (0, 25, 50, 100 µM) in the presence of IQ (50 µM). Lymphocytes from healthy individuals served as the control groups. After the treatment, the cells were pelleted (5 minutes at 900 g). For DNA damage studies, the cell suspension was mixed with the same volume of 1% low melting point agarose for the Comet assay.

2.6.2. Treatment for colorectal cancer group of experiments

Lymphocyte suspensions (100 µl, 106 cells per ml) from colon cancer patients (n=20) and healthy controls (n=20) were exposed to defined concentrations of food mutagens and/or flavonoids in the presence of RPMI in a total volume of 1 ml. The treatment was for 30 min at 37 °C. As lymphocytes showed little or no difference in response with metabolic activation, the Comet assay was performed in the absence of metabolic activation to avoid any confounding factors (Anderson, 1997, 1998). To investigate DNA damage, the following concentrations were used 10, 25, 50 and 75 µM for PhIP and 25, 75, 100 and 150 µM for IQ based on preliminary studies (data not shown). To investigate the modulatory effect of flavonoids, the highest concentrations of IQ and PhIP were used for simultaneous combination treatment with the flavonoids, quercetin and rutin, supplemented at concentrations of 100 (50 for rutin), 250 and 500 µM.

2.7. Alkaline comet assay

The slide preparation for the Comet assay and the assay itself was carried out as previously described (Tice et al., 2000). An aliquot of 100 µl of lymphocyte suspension was mixed with 100 µl of 1% low melting point agarose (in PBS, <40 °C warm) and 100 µl of this suspension were spread onto each of the two microscope glass slides pre-coated with 1% normal melting point agarose (in water, dried overnight). After cover-slips were applied, the slides were placed on an ice-cold tray. Once the agarose set, the cover-slips were removed and a final third layer of 0.5% low melting point agarose (in PBS) was added and allowed to solidify as well on ice for 5 min. For each concentration, two replicate slides were produced. For cell lysis, the slides were immersed laterally in a container with cold lysing solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 10% DMSO, 1% Triton X-100, pH 10) and incubated at 4 ºC overnight. Then, the slides were placed on the tray of an electrophoresis tank, filled with cold alkaline electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH <13) and incubated for 30 minutes at 4 ºC in the dark to allow the unwinding of DNA and expression of alkali labile sites. Electrophoresis was conducted at the same temperature for 30 minutes at 0.75 V/cm. The current was adjusted to 300 mA by raising or lowering the buffer level. After electrophoresis, the slides were removed from the tank and soaked three times for 5 minutes each with neutralizing Tris buffer (400 mM, pH 7.4). Cellular DNA was stained with 60 µl of 20 µg/ml ethidium bromide and cover-slips applied. Slides were examined using a fluorescence microscope equipped with a charge couple device (CCD) monochrome camera and a computerised image analysis system, Komet 4.0 (Kinetic Imaging, Liverpool, UK) to measure the comet parameters. All slides were coded by an independent person ensuring that scoring took place completely randomized and in a “blind” manner (Faust et al., 2004). For each replicate slide, 25 cells were scored (50 cells in total) for each individual in each group making 500-1000 observations per experimental point, allowing a more than adequate statistical power to detect effects (Hartmann et al., 2003).

2.8. Statistical analysis

Data were tested for normality prior to statistical analysis. Normal distributions were checked through the Kolmogorov-Smirnoff and Shapiro-Wilk’s Test to assess whether parametric statistics could be used. Study I: Gaussian normality was violated for many of the scale variables as endorsed by the Kolmogorov-Smirnov test. Therefore, non-parametric test procedures were adopted wherever necessary, such as the Kruskal-Wallis (K-W) and the Mann-Whitney (M-W) tests for independent samples. When testing intra-subject differences in DNA damage, the Wilcoxon Signed Rank (WSR) test was applied. For the binary response variables, Fisher's Exact (FE) test was applied. Throughout the analyses, a significance level of 5% was used and unilateral alternative hypotheses preferred to bidirectional tests (wherever appropriate). Study II: differences in measured parameters between healthy and colon cancer subjects were assessed by the parametric One Way ANOVA Test, since data were normally distributed. The relationship between DNA damage and various parameters characterising colon cancer status and unexposed control was analyzed using Post-hoc analysis (Dunnett test). The mean of each set of data was used in the statistical analysis. A probability level at p<0.05 was regarded as statistically significant. Differences between two experimental groups were tested by the unpaired Student t-test when comparing confounding factors due to gender, diet, smoking and drinking habits. The SPSS package version 16 was used to compare patient and control groups at different doses of H2O2, food mutagens and flavonoids.

Statistical analyses were performed on mean values for each cluster group (healthy individuals, IBD and colon cancer patients) for each possible combination of chemicals. The experimental unit was the individual. The Comet data parameters used to measure DNA damage were Olive tail moment (OTM; arbitrary unit, the fraction of DNA in the tail multiplied by the tail length) and % tail DNA (the percentage of DNA in the tail) recommended to be the most reliable comet measurements with OTM being the most statistically significant (Kumaravel and Jha, 2006). Of these two parameters, OTM is one of the most commonly reported measures of DNA damage but is recommended to be provided together with % tail DNA (Tice et al., 2000). Together they clearly define the comets indicating a linear relationship to the DNA break frequency over a wide range of levels of damage and both can be applied for scientific purposes (Hartmann et al., 2003; Kumaravel et al., 2009).

3. Results

Mutagenic effects of food mutagens and H2O2 in lymphocytes of all groups, healthy individuals and IBD/cancer patients, were examined in vitro by comparing the untreated controls to the different treatment doses. Supplementing the treatment with various concentrations of the flavonoids, quercetin, epicatechin and rutin, the reduction of the genotoxic impact of chemicals was also evaluated. The different combined treatments of H2O2/food mutagens and flavonoids were then compared to a positive control being a non-supplemented high dose of H2O2/food mutagens. Subsequently, an intergroup comparison between healthy individuals and IBD/cancer patients was carried out evaluating the baseline DNA damage as well as the difference in sensitivity of lymphocytes of all groups. Also, the contribution of confounding factors was evaluated for all experiments.

3.1. Study I: IBD patients

3.1.1. Patient versus control groups

As shown in Table 1 and Figure 1, there was a significant difference in baseline DNA damage before in vitro treatment in lymphocytes of IBD patients when comparing them with healthy individual controls (p < 0.001). The study groups as well as the control groups after treatment showed significant increases in DNA damage induced by H2O2 (p < 0.001) and IQ (p < 0.001). The induced damage caused by the in vitro treatment with H2O2 or IQ decreased significantly in both groups when co-treated with the flavonoids quercetin or epicatechin, respectively.

Flavonoid supplementation at the highest concentration (250 μM quercetin or 100 μM epicatechin) caused an overall significant reduction of the induced DNA damage within the patient group and the control groups. This resulted in a 48.6% (p < 0.001) reduction of H2O2 induced DNA damage and a 43% (p < 0.001) reduction of IQ induced DNA damage within the patient groups. For both control groups, reductions in DNA damage of 35.2% and 57.1%, respectively, were observed (both, p < 0.001) (Table 1 and Figure 1). As expected, the two different control groups showed similar baseline DNA damage (M-W, p = 0.174).


Table 1.

IBD patient/study and control groups, Olive tail moment (OTM) and % tail DNA after in vitro treatment with H2O2 and IQ and supplementation with the flavonoids at different concentration levels. A1, A2: No treatment; B1: H2O2 50 μM + Quercetin 0 μM ; B2: IQ 50 μM + Epicatechin 0 μM; C1: H2O2 50 μM + Quercetin 100 μM; C2: IQ 50 μM + Epicatechin 25 μM; D1: H2O2 50 μM + Quercetin 200 μM; D2: IQ 50 μM + Epicatechin 50 μM; E1: H2O2 50 μM + Quercetin 250 μM; E2: IQ 50 μM + Epicatechin 100 μM;


Figure 1.

IBD patient group and control group after in vitro treatment with A) H2O2 (50 μM) and supplementation with the flavonoid quercetin (Quer) at different concentration levels and B) IQ (50 μM) and supplementation with the flavonoid epicatechin (Epi) at different concentration levels. Pooling the data for each group and comparing median levels of DNA damage and 75% quartiles showed them to be significantly different (Kolmogorov-Smirnov test, p < 0.001). The º symbols followed by a number indicate individual outliers with the respective patient number.

3.1.2. Differences in IBD sub-groups

As shown in Table 2 and Figure 2 in both series of experiments there was less DNA damage in the UC patient group (n = 4) than in the CD group (n = 4) each being significantly different (Kruskal-Wallis (K-W) test, p < 0.001) when compared with the combined patient groups, which also included the indeterminate group where it was difficult to differentiate into UC or CD (n = 2). Also there was less induced DNA damage in the study group treated with H2O2 and quercetin compared with the study group treated with IQ and epicatechin although the patients were selected randomly.


Figure 2.

DNA damage within three IBD subgroups after in vitro treatment with A) H2O2 (50 μM) and supplementation with the flavonoid quercetin (Quer) at different concentration levels and B) IQ (50 μM) and supplementation with the flavonoid epicatechin (Epi) at different concentration levels. The first two groups were diagnosed with Crohn’s disease and Ulcerative Colitis. The third group was an indeterminate subgroup.

3.1.3. Confounding factors Ethnicity, age, gender, smoking and drinking habits

There were small differences of median levels of DNA damage in Caucasians (n = 13) and Asians (n = 7) after treatment with H2O2 and quercetin as well as in males and females. A similar effect was observed within groups treated with IQ and epicatechin. However, these differences were not found to be statistically significant. There were also no statistically significant differences in DNA damage in the age distributions between patients as well as between control individuals (H2O2 with quercetin experiment: patients’ mean age = 42.4 years ± 11.6, control individuals’ mean age = 28.9 years ± 9.0; IQ with epicatechin experiment: patients’ mean age = 39.2 years ± 10.3, control individuals’ mean age = 22.6 years ± 9.2). No major differences were seen due to smoking and/or drinking habits (Table 2).


Table 2.

Details of patient and control groups relating to confounding factors and their significant differences. OTM – Olive tail moment; # - only patient values included, values for healthy individuals shown in Table 1; ∆ - patient and control group values combined Previous medication in the IBD group as a confounding factor

Patients had been treated with a range of drugs for IBD, namely, azathioprine, mesalazine and pentasa, asacol, prednisolone, mercaptopurine alone or in combination prior to taking part in the study. Azathioprine & pentasa, azathioprine & mesalazine, mercaptopurine & balsalazide (n = 6); asacol (n = 1); pentasa & prednisolone, prednisolone & mesalazine (n = 3). Within the treatment groups, there appeared to be differences but they were not significant.

3.2. Study II: colon cancer patients

3.2.1. Patient versus control groups

Treating lymphocytes from healthy individuals and cancer patients with food mutagens IQ and PhIP in vitro resulted in a dose-dependent statistically significant induction of DNA damage for both parameters measured, Olive tail moment (OTM) and % tail DNA (Table 3). For the 25μM IQ treatment of lymphocytes from colon cancer patients, the induced DNA damage measured in % tail DNA reached significance while the evaluated OTM did not.


Table 3.

DNA damage induced in vitro in lymphocytes from healthy individuals and colon cancer patients by the food mutagens IQ and PhIP and its reduction by flavonoid supplementation with various concentrations of quercetin (Q) and rutin (R).

Significantly different from the negative control: * p<0.05; ** p<0.01; *** p<0.001Significantly different from highest dose of food mutagen IQ: p<0.05; †† p<0.01; ††† p<0.001Significantly different from healthy individuals: § p<0.05; §§ p<0.01; §§§ p<0.001

Different concentrations of the flavonoids quercetin (100, 250 and 500 µM) and rutin (50, 250 and 500 µM) showed modulating effects on human lymphocytes of both donor groups in the presence of high doses of food mutagens, 150 µM IQ or 75 µM PhIP (Table 3). In the majority of the experiments supplementation with flavonoids resulted in a significant dose-dependent reduction of the induced DNA damage ranging from 1.4 to 2.5 times. For lymphocytes from healthy individuals, only the lowest quercetin dose together with IQ and the lowest dose for rutin together with IQ and PhIP measured in OTM, as well as the lowest dose of rutin together with PhIP when evaluating % tail DNA did not reach significant levels. At the highest supplemented flavonoid dose, the DNA damage from a high dose of food mutagen was significantly reduced to levels of damage in lymphocytes (from both donor groups) which was comparable to a treatment with a six times lower dose of the food mutagen IQ and a 7.5 times lower dose of PhIP, respectively.

Intergroup comparisons showed lower basic DNA damage in lymphocytes from healthy individuals (negative control) when compared to those from colon cancer patients (Figure 3 and Table 3). This difference was highly significant (p < 0.001 for parameters, OTM and % tail DNA) for the negative control of the IQ experiment and significant for the PhIP experiment (p < 0.05 for % tail DNA; the OTM parameter did not reach significance: p = 0.085). Also, after treatment with food mutagens IQ and PhIP this higher baseline damage led to a significantly higher induction of DNA damage in lymphocytes from cancer patients for IQ concentrations of 25 µM (p < 0.01 for OTM; p < 0.001 for % tail DNA), 75 µM (p < 0.05 for % tail DNA) and 150 µM (p < 0.05 for OTM) as well as PhIP concentrations of 10 µM (p < 0.05 for % tail DNA) and 50 µM (p < 0.05 for OTM & % tail DNA).


Figure 3.

The Comet parameter % tail DNA is shown indicating DNA damage in lymphocytes after in vitro treatment with IQ (25, 75, 100 and 150 µM) and then supplementation of the highest dose with either the flavonoid quercetin (Q) [Panel A] or rutin (R) [Panel B] as well as treatment with PhIP (10, 25, 50 and 75 µM) and then supplementation of the highest dose with either the flavonoid quercetin (Q) [Panel C] or rutin (R) [Panel D]. The flavonoids were used at different concentrations from 50 µM up to 500 µM. Intergroup comparisons of healthy individuals and colon cancer patients revealed significantly increased induction of DNA damage, when treating with heterocyclic amines alone and together with flavonoids, between healthy individuals and the colon cancer patient group (* p<0.05, ** p<0.01, *** p<0.001). All other types of data comparisons are shown in Table 3.

When supplementing a single high-dose treatment of either IQ (150 µM) or PhIP (75 µM) with flavonoids (quercetin or rutin), the intergroup comparison showed only at the highest levels of flavonoid supplementation significant differences in the reduction of DNA damage caused by the food mutagen (Figure 3 and Table 3). Except for the supplementation of PhIP with 500 µM of quercetin (Figure 3C), lymphocytes from colon cancer patients showed significantly higher amounts of DNA damage at higher flavonoid concentrations in comparison to healthy volunteers (Figures 3A, 3B & 3D), i.e. less reduction of induced damage by the flavonoid (IQ + 500 µM quercetin, p < 0.01 for OTM and % tail DNA; IQ + 250 µM quercetin, p < 0.01 for % tail DNA; IQ + 500 µM rutin, p < 0.01 for % tail DNA; PhIP + 500 µM rutin, p < 0.05 for OTM and p < 0.01 for % tail DNA). The parameter % tail DNA for genetic damage was more sensitive compared to OTM.

3.2.2. Confounding factors

Confounding factors such as age, gender, diet, smoking habits and alcohol intake were also investigated (Table 4). A significant higher baseline DNA damage (p < 0.001) in lymphocytes from colon cancer patients was observed for parameters OTM and % tail DNA compared to those from healthy individuals. There was also a significant difference between subjects of >50 years of age when compared to those under 50 years of age (p < 0.01) showing a 1.80-fold and 1.54-fold increased baseline DNA damage for OTM and % tail DNA, respectively. No statistically significant differences were found when focusing on smoking habits, alcohol intake and diet, although, when comparing Western to Asian/vegetarian type diet the OTM parameter almost reached significance (p = 0.061). DNA damage in male lymphocytes was significantly (p < 0.05) higher than in lymphocytes from females for the Comet assay parameter % tail DNA but not for the OTM parameter (p = 0.450).


Table 4.

Confounding factors for healthy individuals and colon cancer patients and their influence on the baseline DNA damage using the Comet assay. Significantly different from the negative control: * p<0.05; ** p<0.01; *** p<0.001. OTM - Olive tail moment; % tail DNA- fraction of DNA in the tail; ∆ - patient and control group values combined

4. Discussion

Crohn’s disease (CD) and Ulcerative Colitis (UC), known as inflammatory bowel disease (IBD), are fairly common chronic inflammatory conditions of the gastrointestinal tract. Although the exact aetiology of IBD remains uncertain, dysfunctional immunoregulation of the gut is believed to be the main cause. Amongst the immunoregulatory factors, reactive oxygen species (Seegert et al., 2001) are produced in abnormally high levels in IBD (Rezaie et al., 2007). An imbalance between antioxidants and ROS results in oxidative stress, leading to cellular damage (Rezaie et al., 2007) and subsequently cell death or cancer. Colorectal cancer is a heterogeneous neoplasm consisting of cancer cells with various proliferation rates and the potential to metastasise (Ozdemirler Erata et al., 2005). Genetic alterations caused by cellular overproduction of ROS are required for neoplastic progression (Soderlund et al., 2010). Such changes are based on DNA damage triggered by endogenous but also by environmental and lifestyle genotoxins (Bartsch et al., 2002; Ozdemirler Erata et al., 2005). As the onset of cancer is a prolonged multi-stage process where successive mutations are accumulated, continuous erosion of the genome and defects in repair contribute to this process (Hoeijmakers, 2001; Jiricny and Marra, 2003). Several factors, depending on the socio-economical status, such as large amounts of salted, cured and smoked foods, dietary mutagens, alcohol and obesity may play an important role in increasing mutagenicity leading to an inappropriate stimulation of the immune response or release of ROS subsequently generating further DNA damage (Hursting et al., 2003).

Cooking fish and beef inevitably generate HCA especially at high temperatures (Schut et al., 1999), which are carcinogenic in mice, rats and monkeys producing hepatic, intestinal and mammary tumours (Schoeffner and Thorgeirsson, 2000) and posing a potential risk to humans. HCA have been widely investigated and all of them have so far been described as mutagenic and carcinogenic (Gooderham et al., 2007). Food-derived heterocyclic amines (HCA) like IQ have been shown to be mutagenic in the Ames test inducing gene mutations and tumours in vivo (Adamson and Thorgeirsson, 1995; Knize et al., 1995). Food mutagens may cause different types of DNA damage from chromosomal aberrations to subtle nucleotide alterations. Most food mutagens like HCA are able to form reactive DNA adducts by covalently binding to nucleotides. However the effect of food mutagens in carcinogenesis can be modified by heritable traits, namely, low-penetrant genes that affect exposure of the mutagen to DNA through metabolic activation and detoxification or other cellular responses to DNA damage. There is strong evidence that endogenous liver and kidney enzymes or those from commensal bacteria in the intestine are able to metabolically activate HCA which in turn generate DNA damage (El-Zein et al., 2006; Krul et al., 2000). Able to activate and detoxify heterocyclic amines may be enzymes like CYP1A2, N-acetyltransferase, sulfotransferase, prolyl tRNA synthetase, phosphorylase and COX isomers (Wolz et al., 2000). In a recent case-control study, no associations were found between colorectal cancer (CRC) risk and polymorphisms within the genes of those enzymes (Sachse et al., 2002). This comprehensive analysis, however, failed to consider commensal bacteria and their potential impact on HCA activation, an effect independent of the host genotype. The pro-carcinogen IQ is predominantly produced through the pyrolysis of creatinine with sugars and becomes significantly mutagenic in the presence of hepatic microsomes (Sugimura and Sato, 1983). Anaerobic colonic bacteria can convert IQ to 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline-7-one (HOIQ), a direct-acting mutagen (Bashir et al., 1987). These commensal bacteria can strongly influence IQ-induced DNA damage in colonic cells and also in hepatocytes as measured by the alkaline comet assay (Knasmuller et al., 2001).

As mentioned before DNA damage seems to be also triggered by oxidative stress. When considering the human diet, it should be recognized that food contains both, mutagens and components that decrease cancer risk such as antioxidants (Goldman et al., 2003; Maeda et al., 1999). Flavonoids are known to have antioxidative properties in vivo (Rice-Evans, 2001) and modulate effects of food mutagens in vitro in human lymphocytes and sperm (Anderson et al., 1998). Green tea and, to a lesser extent, black tea are a rich source of still another group of flavonoids called catechins. The activity of quercetin is believed to be due to its antioxidative properties, however, it has been suggested that quercetin may also have pro-oxidative activities, which might then directly affect genotoxicity (Lee et al., 2003). Conclusively, quercetin acts as a strong antioxidant and scavenger of free radicals while it might simultaneously undergo an oxidation process giving rise to the formation of the semiquinone radical (Papiez et al., 2008).

The present studies demonstrate that H2O2, PhIP and IQ are capable of inducing significant DNA damage as a result of oxidative stress (Figures 1, 2 and 3, Table 1 and 3). There was a significant increase of DNA damage after treating lymphocytes from healthy controls, IBD and colon cancer patients with H2O2, PhIP and IQ, while a significant protective effect was found in the presence of the flavonoids quercetin, rutin and epicatechin (Figures 1, 2 and 3, Table 1 and 3).

In the study I, the protective in vitro effect of quercetin and epicatechin against oxidative stress in lymphocytes from IBD patients and healthy individuals (Figure 1) was observed. We were able to show that untreated lymphocytes from IBD patients had significantly increased DNA damage when compared to healthy individuals as shown previously with other IBD patients (Najafzadeh et al., 2007). In vitro treatment with H2O2 and IQ significantly induced DNA damage by oxidative stress in both groups. Flavonoids reduced the baseline DNA damage in lymphocytes from IBD patients treated with H2O2 and IQ. Similar effects were achieved with Chaga mushroom extracts (Najafzadeh et al., 2007). When co-treated with flavonoids, a significant protective effect was shown against free radical damage to the DNA generated by H2O2 or IQ (Figure 1). There was a very high level of damage in the patient group without any treatment because of their background inflammation and IBD therapeutic drugs which they had taken, but both patients and controls showed a parallel and gradual reduction in DNA damage after treating with flavonoids (Figure 1 and Table 1).

Lymphocytes from CD patients in two series of study groups appeared to have a greater level of baseline DNA damage than those from UC patients when compared to the whole patient group (p < 0.001), suggesting that lymphocytes from CD patients are more exposed to oxidative stress than other IBD subgroups (Figure 2). It becomes obvious that an excessive production of ROS and radical nitrogen metabolites occur during the inflammation of the intestine in IBD patients (Kruidenier et al., 2003). It seems that a misbalanced production of pro-inflammatory and anti-inflammatory cytokines is characteristic of IBD and severely affects the immune homeostasis in peripheral blood cells, even more in CD than in UC patients (Sventoraityte et al., 2008). However, all subgroups react in the same way towards exogenous oxidative stressors as well as towards the inhibition of oxidative stress by flavonoids.

The detrimental effects of two common food mutagens, IQ and PhIP, on the DNA were investigated in study II by treating in vitro lymphocytes from healthy individuals and from patients diagnosed with colon cancer. Pool-Zobel et al. found lymphocytes responses to be very similar to responses in rectal cells (Pool-Zobel et al., 2004), thus, supporting their role as surrogate cells for biomonitoring and in-vitro treatments. Both HCA caused in a dose-dependent manner similar levels of DNA damage in lymphocytes of both groups for the Comet assay parameters OTM and % tail DNA (Table 3), supporting the classification for IQ as “probably carcinogenic to humans” and for PhIP as “possibly carcinogenic to humans” (IARC, 1993). Higher doses significantly increased the induced DNA damage. IQ and PhIP were shown to be potent genotoxins and carcinogens (Adamson et al., 1995; Durling and Abramsson-Zetterberg, 2005; Duthie et al., 1997). Even very low doses (10-3 to 10-4 µM PhIP) induce expression of the DNA damage response proteins like p53 and increase proliferation in oestrogen receptor (ER)-negative MCF10A cells (Gooderham et al., 2007). Hence, PhIP may induce/enhance carcinogenicity via DNA damage and/or oestrogen receptors (Bennion et al., 2005; Felton et al., 2004). IQ on the other hand can form DNA adducts like N-(deoxyguanosin-8-yl)-IQ in the presence of nitric oxide constituting a possible cancer risk for individuals with colon inflammation (Lakshmi et al., 2008).

In our study the DNA damage induced in lymphocytes of both donor groups by food mutagens IQ and PhIP was effectively and dose-dependently reduced by supplementation with the flavonoids quercetin and rutin (Table 3). The level of DNA damage from the highest HCA dose reduced by the highest dose (500 µM) of flavonoids was comparable to that of a six times (for IQ) and 7.5 times (for PhIP) lower non-supplemented dose of food mutagen.

Strong antioxidative effects of flavonoids to protect against DNA damage have been known for some time (Anderson et al., 2003; Collins, 2005; Perez-Vizcaino et al., 2009; Rice-Evans, 2001) and in-vitro experiments on human colonocytes suggested that especially quercetin plays a crucial role in the defence against oxidative insults (Duthie and Dobson, 1999). In human lymphocytes quercetin and rutin already showed a dose-dependently protective effect against DNA damage caused by the mutagenic anticancer drug mitomycin C (Undeger et al., 2004). However, neither myricetin, quercetin nor rutin increased the rate of DNA strand break repair in various cell types such as Caco-2, Hep G2 and V79 (Aherne and O'Brien, 2000).

We found that the number of individuals in each group was sufficient to establish statistically significant responses (p< 0.001) shown in our study for the food mutagens. Our results indicate that the baseline DNA damage was higher for all experiments in lymphocytes from colon cancer patients when compared to healthy individuals (Table 3 and Figure 3). Disease states which involve an overproduction of ROS may therefore inflict significantly higher DNA damage in peripheral lymphocytes from patients when compared to the baseline level of damage in healthy individuals. This has been shown for diseases like Irritable Bowel Syndrome and diabetes (Collins et al., 1998b; Najafzadeh et al., 2009; Wyatt, 2006). It also confirms findings of Vodicka et al. who observed increased chromosomal damage in lymphocytes of newly diagnosed cancer patients compared with healthy controls (Vodicka et al., 2010). Similar observations of a higher baseline DNA damage were made for head and neck squamous cell carcinoma patients (Palyvoda et al., 2003) and breast cancer patients (Rajeswari et al., 2000; Smith et al., 2003) in addition to higher levels of cytogenetic damage (Palyvoda et al., 2003). Even the modulating effect of flavonoids in a co-treatment with a high dose of food mutagen (Table 3) seem to be affected by the higher baseline damage as the induced DNA damage in lymphocytes from colon cancer patients was not reduced to the levels of healthy individuals. Except for the supplementation of PhIP with 500 µM of quercetin (Figure 3C), lymphocytes from colon cancer patients showed significantly higher amounts of DNA damage at higher flavonoid concentrations (Figures 3A, 3B & 3D), i.e. less reduction of induced damage, that may suggest that higher concentrations of flavonoids would be required to achieve a protective effect. A possible reason for this finding could be a reduced repair capacity which was found for breast cancer patients after in-vitro treatment of lymphocytes with N-methyl-N-nitro-N-nitrosoguanidine or ionising radiation (Smith et al., 2003). The repair capacity of first degree relatives to these patients was also decreased (Rajeswari et al., 2000; Smith et al., 2003). These differences in repair capacity may either be an effect of cancer per se due to a changed lymphocyte population alongside the oncogenic process, or a higher DNA damage and slower repair among some individuals who may be more predisposed to develop cancer (Palyvoda et al., 2003).

An analysis of confounding factors such as age, gender, diet, smoking habits and alcohol intake (Table 4) on the baseline level of DNA damage in lymphocytes in Study II showed a significant higher damage for subjects of >50 years of age (p < 0.01) as previously reported (King et al., 1994; Mendoza-Nunez et al., 2001). When examining the confounding effect aspects the numbers of participants were reduced yet we still found statistically significant effects for age (>50. p < 0.01) for both OTM and % tail DNA and for gender (males, p < 0.05) for % tail DNA only. An increase in DNA damage in lymphocytes has been observed among elderly individuals but was not significant (Betti et al., 1994; Mendoza-Nunez et al., 2001). We are aware our groups are not best matched for age however these were the only individuals available at the time. Despite this fact we were able to detect an age effect in a >50 age group. Although smoking and alcohol consumption is associated with an increased risk for colorectal cancer (Bardou et al., 2002; Emmons et al., 2005) probably due to DNA damage via increased levels of oxidative stress (Lodovici and Bigagli, 2009; Obe and Anderson, 1987; Pool-Zobel et al., 2004), no statistically significant differences were found in our study when focussing on smoking habits, alcohol intake or diet. This was also the case in the IBD study (Study I). DNA damage in male lymphocytes, however, was significantly higher than in lymphocytes from females for the Comet assay parameter % tail DNA but not for OTM. According to the literature, male gender constituted a risk factor for DNA damage (Collins et al., 1998a), where elderly males had more than twice the probability of having DNA damage than females (Mendoza-Nunez et al., 2001). After in vitro treatment with IQ and PhIP an increase in DNA damage in lymphocytes was observed in our study but confounding factors such as diet, smoking and drinking habits did not seem to influence this response, even though numerous environmental and lifestyle compounds can have an impact on the exposure, metabolism and cell proliferation response of HCA (Felton et al., 2004). Nevertheless, in most of the cases the damage was similarly distributed and the general response to treatment may still be dependent on possible dietary interactions after exposure to food mutagens and individual factors like individual susceptibility, cellular antioxidant / micronutrient levels or disease states (Airoldi et al., 2004; El-Zein et al., 2006; Ferguson and Philpott, 2008; Han et al., 2008; Pool-Zobel et al., 2004). It has been estimated that up to 90% of the cases of colorectal cancer could be prevented with life style modifications such as balanced diet, avoidance of smoking and alcohol and physical activity (Boursi and Arber, 2007).

5. Conclusion

In conclusion, a significant protective effect of the flavonoids quercetin, epicatechin and rutin against oxidative DNA damage has been demonstrated after oxidative stress has been induced in vitro by H2O2, heterocyclic amines IQ and PhIP in lymphocytes obtained from IBD and colon cancer patients and healthy individuals. Lymphocytes from IBD, cancer patients and controls had increased DNA damage possibly due to an overproduction of ROS and there was a significant difference in response between all donor groups to treatment with HCA alone and together with flavonoids in both studies. It is believed that flavonoids operate through their antioxidant properties and responses of H2O2 and HCA to quercetin, epicatechin and rutin observed throughout the study, support the hypothesis that food mutagens target DNA by generating ROS. Concepts such as chemoprevention specifically focus on the long-term use of protective agents like vitamins (Boursi et al., 2007; Das et al., 2007). As shown, flavonoids have impressive antioxidant properties and are able to effectively protect the integrity of lymphocytes’ DNA from ROS induced by HCA, which would make them the ideal supplemental compounds to prevent the onset of cancer (Dashwood, 1999; Ross et al., 2002). Although the possible health benefits of consuming flavonoids seem to be obvious, there are so many biological activities attributed to them, that further study may be justified.

The flavonoids significantly reduce DNA damage in vitro in lymphocytes of IBD and colorectal cancer patients as well as healthy individuals. Thus, a diet containing flavonoids could be very effective in reducing baseline and exogenously induced oxidative DNA damage of IBD and colorectal cancer patients.


The authors want to thank the clinical staff of Bradford Royal Infirmary Hospital and St. Luke’s Hospital for their support in this study.


1 - R. H. Adamson, U. P. Thorgeirsson, 1995Carcinogens in foods: heterocyclic amines and cancer and heart disease.Advances in Experimental Medicine and Biology3692112200065-2598
2 - R. H. Adamson, U. P. Thorgeirsson, T. Sugimura, 1996Extrapolation of heterocyclic amine carcinogenesis data from rodents and nonhuman primates to humans.Archives of ToxicologySupplement, 183033180171-9750
3 - S. A. Aherne, N. M. O’Brien, 2000Lack of effect of the flavonoids, myricetin, quercetin, and rutin, on repair of H2O2-induced DNA single-strand breaks in Caco-2, Hep G2, and V79 cells.Nutrition and cancer3811061150163-5581
4 - L. Airoldi, C. Magagnotti, R. Pastorelli, R. Fanelli, 2004Enzyme polymorphisms influencing the metabolism of heterocyclic aromatic amines.Journal of ChromatographyB, Analytical Technologies in the Biomedical and Life Sciences, 8021March 2004), 1751811570-0232
5 - D. Anderson, T. W. Yu, B. J. Phillips, P. Schmezer, 1994The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay.Mutation Research3071May 1994), 2612710027-5107
6 - D. Anderson, N. Basaran, M. M. Dobrzynska, A. A. Basaran, T. W. Yu, 1997Modulating effects of flavonoids on food mutagens in human blood and sperm samples in the comet assay.TeratogenesisCarcinogenesis, and Mutagenesis, 17245580270-3211
7 - D. Anderson, M. M. Dobrzynska, N. Basaran, A. Basaran, T. W. Yu, 1998Flavonoids modulate comet assay responses to food mutagens in human lymphocytes and sperm.Mutation Research4021-2June 1998), 2692770027-5107
8 - D. Anderson, T. E. Schmid, A. Baumgartner, E. Cemeli-Carratala, M. H. Brinkworth, J. M. Wood, 2003Oestrogenic compounds and oxidative stress (in human sperm and lymphocytes in the Comet assay)Mutation Research, 5442-3November 2003), 1731780027-5107
9 - C. F. Babbs, 1990Free radicals and the etiology of colon cancer.Free Radical Biology & Medicine821912000891-5849
10 - M. Bardou, S. Montembault, V. Giraud, A. Balian, E. Borotto, C. Houdayer, F. Capron, J. C. Chaput, S. Naveau, 2002Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control studyGut, 501January 2002), 38420017-5749
11 - H. Bartsch, J. Nair, R. W. Owen, 2002Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: potential role of lipid peroxidation, dietary fat and antioxidants.Biological Chemistry3836September 2002), 9159211431-6730
12 - M. Bashir, D. G. Kingston, R. J. Carman, R. L. van Tassell, T. D. Wilkins, 1987Anaerobic metabolism of 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) by human fecal flora.Mutation Research1903March 1987), 1871900027-5107
13 - B. J. Bennion, M. Cosman, F. C. Lightstone, M. G. Knize, J. L. Montgomery, L. M. Bennett, J. S. Felton, K. S. Kulp, 2005PhIP carcinogenicity in breast cancer: computational and experimental evidence for competitive interactions with human estrogen receptor.Chemical Research in Toxicology1810March 2006), 152815360089-3228X
14 - C. Betti, T. Davini, L. Giannessi, N. Loprieno, R. Barale, 1994Microgel electrophoresis assay (comet test) and SCE analysis in human lymphocytes from 100 normal subjectsMutation Research3071May 1994), 3233330027-5107
15 - K. T. Bogen, 1994Cancer potencies of heterocyclic amines found in cooked foods.Food and Chemical Toxicology, 326June 1994), 5055150278-6915
16 - A. W. Boots, G. R. Haenen, A. Bast, 2008Health effects of quercetin: from antioxidant to nutraceutical.European Journal of Pharmacology5852-3May 2008), 3253370014-2999
17 - B. Boursi, N. Arber, 2007Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention.Current Pharmaceutical Design1322227422821873-4286
18 - L. M. Butler, R. Sinha, R. C. Millikan, C. F. Martin, B. Newman, M. D. Gammon, A. S. Ammerman, R. S. Sandler, 2003Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. American Journal of Epidemiology, 1575March 2003), 4344450002-9262
19 - N. Chondriogianni, S. Kapeta, I. Chinou, K. Vassilatou, I. Papassideri, E. S. Gonos, 2010Anti-ageing and rejuvenating effects of quercetin. Experimental Gerontology, 45107637711873-6815
20 - A. R. Collins, 2005Antioxidant intervention as a route to cancer prevention.European Journal of Cancer, 4113September 2005), 192319300959-8049
21 - A. R. Collins, C. M. Gedik, B. Olmedilla, S. Southon, M. Bellizzi, 1998aOxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality rates.The FASEB Journal, 1213October 1998), 139714000892-6638
22 - A. R. Collins, K. Raslova, M. Somorovska, H. Petrovska, A. Ondrusova, B. Vohnout, R. Fabry, M. Dusinska, 1998bDNA damage in diabetes: correlation with a clinical markerFree Radical Biology and Medicine, 2533733770891-5849
23 - S. Danese, C. Fiocchi, 2006Etiopathogenesis of inflammatory bowel diseases.World Journal of Gastroenterology, 1230August 2006), 480748121007-9327
24 - D. Das, N. Arber, J. A. Jankowski, 2007Chemoprevention of colorectal cancerDigestion76151671421-9867
25 - R. H. Dashwood, 1999Early detection and prevention of colorectal cancer (review).Oncology Reports622772810102-1335X
26 - K. J. Davies, 1995Oxidative stress: the paradox of aerobic life.Biochemical Society Symposium611310067-8694
27 - L. J. Durling, L. Abramsson-Zetterberg, 2005A comparison of genotoxicity between three common heterocyclic amines and acrylamide.Mutation Research5801-21031100027-5107
28 - S. J. Duthie, W. Johnson, V. L. Dobson, 1997The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimdines) and growth in human cells.Mutation Research3901-2April 1997), 1411510027-5107
29 - S. J. Duthie, V. L. Dobson, 1999Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro.European Journal of Nutrition381May 1999), 28341436-6207
30 - G. Eisenbrand, W. Tang, 1993Food-borne heterocyclic amines. Chemistry, formation, occurrence and biological activities. A literature review.Toxicology841-31820030-0483X
31 - R. El -Zein, C. J. Etzel, M. S. Lopez, Y. Gu, M. R. Spitz, S. S. Strom, 2006Human sensitivity to PhIP: a novel marker for prostate cancer riskMutation Research6011-2October 2006), 1100027-5107
32 - K. M. Emmons, C. M. Mc Bride, E. Puleo, K. I. Pollak, B. H. Marcus, M. Napolitano, E. Clipp, J. Onken, F. A. Farraye, R. Fletcher, 2005Prevalence and predictors of multiple behavioral risk factors for colon cancer.Preventive Medicine405May 2005), 5275340091-7435
33 - F. Faust, F. Kassie, S. Knasmuller, R. H. Boedecker, M. Mann, V. Mersch-Sundermann, 2004The use of the alkaline comet assay with lymphocytes in human biomonitoring studies.Mutation Research5663May), 209229
34 - J. S. Felton, M. G. Knize, L. M. Bennett, M. A. Malfatti, M. E. Colvin, K. S. Kulp, 2004Impact of environmental exposures on the mutagenicity/carcinogenicity of heterocyclic aminesToxicology1981-3May 2004), 1351450030-0483X
35 - J. S. Felton, M. G. Knize, R. W. Wu, M. E. Colvin, F. T. Hatch, M. A. Malfatti, 2007Mutagenic potency of food-derived heterocyclic aminesMutation Research, 6161-2March 2007), 90940027-5107
36 - L. R. Ferguson, M. Philpott, 2008Nutrition and mutagenesisAnnual Review of Nutrition283133290199-9885
37 - R. Goldman, P. G. Shields, 2003Food mutagens. The Journal of Nutrition, 133Suppl 3, (March), 965S973S0022-3166
38 - N. J. Gooderham, S. Creton, S. N. Lauber, H. Zhu, 2007Mechanisms of action of the carcinogenic heterocyclic amine PhIPToxicology Letters1683February 2007), 2692770378-4274
39 - M. J. Gunter, N. M. Probst-Hensch, V. K. Cortessis, M. Kulldorff, R. W. Haile, R. Sinha, 2005Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case-control studyCarcinogenesis, 263March 2005), 6376420143-3334
40 - J. F. Han, X. Y. He, J. S. Herrington, L. A. White, J. F. Zhang, J. Y. Hong, 2008Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human CYP1B1 genetic variantsDrug Metabolism and Dispositionthe biological fate of chemicals, 364April 2008), 7457520152-1009X
41 - A. Hartmann, E. Agurell, C. Beevers, S. Brendler-Schwaab, B. Burlinson, P. Clay, A. Collins, A. Smith, G. Speit, V. Thybaud, R. R. Tice, 2003Recommendations for conducting the in vivo alkaline Comet assayth International Comet Assay Workshop. Mutagenesis181January 2003), 45510267-8357
42 - F. T. Hatch, M. G. Knize, M. E. Colvin, 2001Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting mutagenic potency.Environmental and Molecular Mutagenesis3842682910893-6692
43 - T. Hemnani, M. S. Parihar, 1998Reactive oxygen species and oxidative DNA damage.Indian Journal of Physiology and Pharmacology424October 1998), 4404520019-5499
44 - L. Henderson, A. Wolfreys, J. Fedyk, C. Bourner, S. Windebank, 1998The ability of the Comet assay to discriminate between genotoxins and cytotoxins.Mutagenesis131March 1998), 89940267-8357
45 - J. H. Hoeijmakers, 2001Genome maintenance mechanisms for preventing cancer.Nature4116835May 2001), 3663740028-0836
46 - P. C. H. Hollman, M. G. L. Hertog, M. B. Katan, 1996Analysis and health effects of flavonoidsFood Chemistry5714346
47 - M. H. Hopkins, V. Fedirko, D. P. Jones, P. D. Terry, R. M. Bostick, 2010Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trialCancer Epidemiology, Biomarkers & Prevention, 193March 2010), 8508581538-7755
48 - S. D. Hursting, J. A. Lavigne, D. Berrigan, S. N. Perkins, J. C. Barrett, 2003Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annual Review of Medicine, 541311520066-4219
49 - IARC.1993Monographs on the evaluation of carcinogenic risks to human: some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins.56165229
50 - J. Jiricny, G. Marra, 2003DNA repair defects in colon cancer.Current Opinion in Genetics & Development131February 2003), 61690095-9437X
51 - G. Kaur, M. Roberti, F. Raul, U. R. Pendurthi, 2007Suppression of human monocyte tissue factor induction by red wine phenolics and synthetic derivatives of resveratrolThrombosis Research11922472560049-3848
52 - C. M. King, E. S. Gillespie, P. G. Mc Kenna, Y. A. Barnett, 1994An investigation of mutation as a function of age in humans.Mutation Research3162August 1994), 79900027-5107
53 - S. Knasmuller, H. Steinkellner, A. M. Hirschl, S. Rabot, E. C. Nobis, F. Kassie, 2001Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic aminesMutation Research480-481September 2001), 1291380027-5107
54 - M. G. Knize, F. A. Dolbeare, P. L. Cunningham, J. S. Felton, 1995Mutagenic activity and heterocyclic amine content of the human dietPrincess Takamatsu Symposia, 233038
55 - M. G. Knize, J. S. Felton, 2005Formation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meat.Nutrition Reviews635May 2005), 1581650029-6643
56 - L. Kruidenier, I. Kuiper, C. B. Lamers, H. W. Verspaget, 2003Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.The Journal of Pathology2011September 2003), 2836
57 - C. Krul, A. Luiten-Schuite, R. Baandagger, H. Verhagen, G. Mohn, V. Feron, R. Havenaar, 2000Application of a dynamic in vitro gastrointestinal tract model to study the availability of food mutagens, using heterocyclic aromatic amines as model compounds.Food and Chemical Toxicology, 389September 2000), 7837920278-6915
58 - T. S. Kumaravel, A. N. Jha, 2006Reliable Comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals.Mutation Research6051-2June 2006), 7160027-5107
59 - T. S. Kumaravel, B. Vilhar, S. P. Faux, A. N. Jha, 2009Comet Assay measurements: a perspectiveCell Biology and Toxicology25November 2007), 5364
60 - V. M. Lakshmi, F. F. Hsu, T. V. Zenser, 2008N-Demethylation is a major route of 2-amino-3-methylimidazo[4,5-f]quinoline metabolism in mouseDrug Metabolism and Dispositionthe biological fate of chemicals, 366June 2008), 114311520152-1009X
61 - J. C. Lee, J. Kim, J. K. Park, G. H. Chung, Y. S. Jang, 2003The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis. Experimental Cell Research, 2912December 2003), 386397
62 - M. Lodovici, E. Bigagli, 2009Biomarkers of induced active and passive smoking damageInternational Journal of Environmental Research and Public Health, 63March 2009), 8748881660-4601
63 - C. Loguercio, G. D’Argenio, Cave. M. Delle, V. Cosenza, N. Della Valle, G. Mazzacca, Blanco. C. del Vecchio, 1996Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats.Digestive Diseases and Sciences416June 1996), 120412110163-2116
64 - H. Maeda, T. Sawa, T. Yubisui, T. Akaike, 1999Free radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH.Cancer Letters1432September 1999), 1171210304-3835
65 - V. M. Mendoza-Nunez, M. A. Sanchez-Rodriguez, R. Retana-Ugalde, L. A. Vargas-Guadarrama, M. A. Altamirano-Lozano, 2001Total antioxidant levels, gender, and age as risk factors for DNA damage in lymphocytes of the elderly.Mechanisms of Ageing and Development1228June 2001), 8358470047-6374
66 - C. Messner, M. Murkovic, 2004Evaluation of a new model system for studying the formation of heterocyclic amines.Journal of ChromatographyB, Analytical Technologies in the Biomedical and Life Sciences, 8021March 2004), 19261570-0232
67 - P. Moller, 2006The alkaline comet assay: towards validation in biomonitoring of DNA damaging exposures.Basic & Clinical Pharmacology & Toxicology984April 2006), 3363451742-7835
68 - M. Murata, M. Kobayashi, S. Kawanishi, 1999Mechanism of oxidative DNA damage induced by a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5f]quinoxaline.Japanese Journal of Cancer Research, 903March 1999), 2682750910-5050
69 - M. A. Murtaugh, Ma K. N. , C. Sweeney, B. J. Caan, M. L. Slattery, 2004Meat consumption patterns and preparation, genetic variants of metabolic enzymes, and their association with rectal cancer in men and women.The Journal of Nutrition1344April 2004), 7767840022-3166
70 - M. Nagao, T. Ushijima, M. Toyota, R. Inoue, T. Sugimura, 1997Genetic changes induced by heterocyclic amines.Mutation Research3761-2May 1997), 1611670027-5107
71 - M. Najafzadeh, P. D. Reynolds, A. Baumgartner, 2007Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease.Biofactors, 31191200
72 - M. Najafzadeh, P. D. Reynolds, A. Baumgartner, D. Anderson, 2009Flavonoids inhibit the genotoxicity of hydrogen peroxide (H(2)O(2)) and of the food mutagen 2-amino-3-methylimadazo[4,5-f]-quinoline (IQ) in lymphocytes from patients with inflammatory bowel disease (IBD). Mutagenesis, 245September 2009), 4054111464-3804
73 - A. Navarro, S. E. Munoz, M. J. Lantieri, Diaz. M. del Pilar, P. E. Cristaldo, S. P. de Fabro, A. R. Eynard, 2004Meat cooking habits and risk of colorectal cancer in Cordoba, Argentina.Nutrition, 20108738770899-9007
74 - M. Noroozi, W. J. Angerson, M. E. Lean, 1998Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes.The American Journal of Clinical Nutrition676June), 121012180002-9165
75 - S. Nowell, B. Coles, R. Sinha, Leod. S. Mac, Ratnasinghe. D. Luke, C. Stotts, F. F. Kadlubar, C. B. Ambrosone, N. P. Lang, 2002Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk.Mutation Research506-507September), 1751850027-5107
76 - G. Obe, D. Anderson, 1987International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 15 1. Genetic effects of ethanol.Mutation Research186No. 3, 1772000027-5107
77 - B. Ossola, T. M. Kaariainen, P. T. Mannisto, 2009The multiple faces of quercetin in neuroprotectionExpert Opinion on Drug Safety8397409
78 - Erata. G. Ozdemirler, O. Kanbagli, O. Durlanik, T. Bulut, G. Toker, M. Uysal, 2005Induced oxidative stress and decreased expression of inducible heat shock protein 70 (ihsp 70) in patients with colorectal adenocarcinomasJapanese Journal of Clinical Oncology352February 2005), 74780368-2811
79 - O. Palyvoda, J. Polanska, A. Wygoda, J. Rzeszowska-Wolny, 2003DNA damage and repair in lymphocytes of normal individuals and cancer patients: studies by the comet assay and micronucleus tests.Acta Biochimica Polonica5011811900000-1527X
80 - M. A. Papiez, A. Cierniak, W. Krzysciak, M. Bzowska, H. M. Taha, A. Jozkowicz, M. Piskula, 2008The changes of antioxidant defense system caused by quercetin administration do not lead to DNA damage and apoptosis in the spleen and bone marrow cells of ratsFood and Chemical Toxicology469September), 305330580278-6915
81 - F. Perez-Vizcaino, J. Duarte, R. Jimenez, C. Santos-Buelga, A. Osuna, 2009Antihypertensive effects of the flavonoid quercetinPharmacological Reports611January-February), 67751734-1140
82 - H. J. Phillips, 1973Dye exclusion tests for cell viability. In Kruse, P.F., Patterson, M.J. (eds), Tissue Culture: Methods and Applications. Academic Press, New York, 406408
83 - B. L. Pool-Zobel, R. G. Klein, U. M. Liegibel, F. Kuchenmeister, S. Weber, P. Schmezer, 1992Systemic genotoxic effects of tobacco-related nitrosamines following oral and inhalational administration to Sprague-Dawley rats.The Clinical Investigator703-4March-April), 2993060941-0198
84 - B. L. Pool-Zobel, I. Dornacher, R. Lambertz, M. Knoll, H. K. Seitz, 2004Genetic damage and repair in human rectal cells for biomonitoring: sex differences, effects of alcohol exposure, and susceptibilities in comparison to peripheral blood lymphocytes.Mutation Research5511-2July), 1271340027-5107
85 - N. Rajeswari, Y. R. Ahuja, U. Malini, S. Chandrashekar, N. Balakrishna, K. V. Rao, A. Khar, 2000Risk assessment in first degree female relatives of breast cancer patients using the alkaline Comet assay.Carcinogenesis214April), 5575610143-3334
86 - A. Rezaie, R. D. Parker, M. Abdollahi, 2007Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Digestive Diseases and Sciences, 529September), 201520210163-2116
87 - C. Rice-Evans, 2001Flavonoid antioxidants.Current Medicinal Chemistry87June), 7978070929-8673
88 - J. A. Ross, C. M. Kasum, 2002Dietary flavonoids: bioavailability, metabolic effects, and safety.Annual Review of Nutrition2219340199-9885
89 - C. Sachse, G. Smith, M. J. Wilkie, J. H. Barrett, R. Waxman, F. Sullivan, D. Forman, D. T. Bishop, C. R. Wolf, 2002A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.Carcinogenesis2311November), 183918490143-3334
90 - D. J. Schoeffner, U. P. Thorgeirsson, 2000Susceptibility of nonhuman primates to carcinogens of human relevance.In Vivo, 141January-February), 1491560025-8851X
91 - H. A. Schut, E. G. Snyderwine, 1999DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis.Carcinogenesis203March), 3533680143-3334
92 - C. E. Schwab, W. W. Huber, W. Parzefall, G. Hietsch, F. Kassie, R. Schulte-Hermann, S. Knasmuller, 2000Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic aminesCritical Reviews in Toxicology301January), 1691040-8444
93 - D. Seegert, P. Rosenstiel, H. Pfahler, P. Pfefferkorn, S. Nikolaus, S. Schreiber, 2001Increased expression of IL-16 in inflammatory bowel disease.Gut483March), 3263320017-5749
94 - A. Shin, M. J. Shrubsole, R. M. Ness, H. Wu, R. Sinha, W. E. Smalley, Y. Shyr, W. Zheng, 2007Meat and meat-mutagen intake, doneness preference and the risk of colorectal polyps: the Tennessee Colorectal Polyp StudyInternational Journal of Cancer1211July), 1361420020-7136
95 - N. J. Simmonds, D. S. Rampton, 1993Inflammatory bowel disease--a radical view.Gut347July), 8658680017-5749
96 - T. R. Smith, M. S. Miller, K. K. Lohman, L. D. Case, J. J. Hu, 2003DNA damage and breast cancer riskCarcinogenesis245May), 8838890143-3334
97 - S. Soderlund, F. Granath, O. Brostrom, P. Karlen, R. Lofberg, A. Ekbom, J. Askling, 2010Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to MalesGastroenterologyFebruary), 1528-001215280012
98 - C. Soffler, 2007Oxidative stress.Veterinary Clinics of North America: Equine Practice, 231May), 1351571558-4224
99 - T. Sugimura, S. Sato, 1983Mutagens-carcinogens in foods.Cancer Research435Suppl, (May), 2415s2421s0008-5472
100 - J. Sventoraityte, A. Zvirbliene, G. Kiudelis, R. Zalinkevicius, A. Zvirbliene, A. Praskevicius, L. Kupcinskas, V. Tamosiunas, 2008Immune system alterations in patients with inflammatory bowel disease during remissionMedicinaKaunas), 4412733
101 - J. Terao, 1999Dietary flavonoids as antioxidants in vivo: conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma. The Journal of Medical Investigation, 463-4August), 1591681343-1420
102 - J. Terao, 2009Dietary flavonoids as antioxidants.Mutation Research, 376211219
103 - R. R. Tice, E. Agurell, D. Anderson, B. Burlinson, A. Hartmann, H. Kobayashi, Y. Miyamae, E. Rojas, J. C. Ryu, Y. F. Sasaki, 2000Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing.Environmental and Molecular Mutagenesis3532062210893-6692
104 - U. Undeger, S. Aydin, A. A. Basaran, N. Basaran, 2004The modulating effects of quercetin and rutin on the mitomycin C induced DNA damage.Toxicology Letters1511June), 1431490378-4274
105 - T. Valachovicova, V. Slivova, D. Sliva, 2004Cellular and physiological effects of soy flavonoids.Mini Reviews in Medicinal Chemistry48October), 8818871389-5575
106 - P. Vodicka, Z. Polivkova, S. Sytarova, H. Demova, M. Kucerova, L. Vodickova, V. Polakova, A. Naccarati, Z. Smerhovsky, M. Ambrus, M. Cerna, K. Hemminki, 2010Chromosomal damage in peripheral blood lymphocytes of newly diagnosed cancer patients and healthy controlsCarcinogenesis31712381241
107 - A. Wach, K. Pyrzynska, M. Biesaga, 2007Quercetin content in some food and herbal samplesFood Chemistry10026997040308-8146
108 - K. Wakabayashi, M. Nagao, H. Esumi, T. Sugimura, 1992Food-derived mutagens and carcinogens.Cancer Research527Suppl, (April), 2092s2098s0008-5472
109 - J. H. Weisburger, W. S. Barnes, C. A. Lovelette, C. Tong, T. Tanaka, G. M. Williams, 1986Genotoxicity, carcinogenicity, and mode of action of the fried food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ).Environmental Health Perspectives, 67August), 1211270091-6765
110 - E. Wolz, W. Pfau, G. H. Degen, 2000Bioactivation of the food mutagen 2-amino-3-methyl-imidazo[4, 5-f]quinoline (IQ) by prostaglandin-H synthase and by monooxygenases: DNA adduct analysis.Food and Chemical Toxicology, 386June), 5135220278-6915
111 - A. H. Wu, D. Shibata, M. C. Yu, M. Y. Lai, R. K. Ross, 2001Dietary heterocyclic amines and microsatellite instability in colon adenocarcinomas.Carcinogenesis2210October), 168116840143-3334
112 - K. Wu, E. Giovannucci, C. Byrne, E. A. Platz, C. Fuchs, W. C. Willett, R. Sinha, 2006Meat mutagens and risk of distal colon adenoma in a cohort of U.S. men.Cancer EpidemiologyBiomarkers & Prevention, 156June 2006), 112011251055-9965
113 - N. Wyatt, 2006Susceptibilities to in vitro chemically-induced DNA damage in human population sub-groups. PhD dissertation, University of Bradford, Bradford, UK
114 - W. Zhou, T. Wirth, M. W. Buchler, A. V. Salnikov, I. Herr, 2010Dietary polyphenol quercetin targets pancreatic cancer stem cellsInternational Journal of Oncology37551561